Zinzino: ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT JANUARY 2025
Zinzino group revenue increased with a total of 57 %, compared with the previous year.
The revenue in January for Zinzino's sales markets increased by 62% and amounted to SEK 228.7 (140.9) million. Faun Pharma's external sales decreased and amounted to SEK 4.7 (8.1) million. Overall, the Group increased revenues by 57% to SEK 233.4 (149.0) million compared with the previous year.
Revenues were distributed as follows:
| Regions, mSEK | 25-Jan | 24-Jan | Change |
| The Nordics | 25.5 | 22.8 | 12% |
| Central Europe | 69.5 | 40.9 | 70% |
| East Europe | 34.2 | 31.8 | 8% |
| South & West Europe | 44.6 | 22.0 | 101% |
| The Baltics | 10.3 | 8.0 | 29% |
| North America | 22.2 | 10.4 | 113% |
| Asia-Pacific | 20.8 | 4.0 | 420% |
| Africa | 1.6 | 1.0 | 60% |
| Zinzino | 228.7 | 140.9 | 62% |
| Faun Pharma | 4.7 | 8.1 | -42% |
| Zinzino Group | 233.4 | 149.0 | 57% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, www.zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Certified Adviser: Carnegie Investment Bank AB (publ.)